newsfilter
← Latest News
GlobeNewswire·

Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th

NEW YORK, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN), an ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, today announced that the Company